Your browser doesn't support javascript.
loading
Phosphorylation of OGFOD1 by Cell Cycle-Dependent Kinase 7/9 Enhances the Transcriptional Activity of RNA Polymerase II in Breast Cancer Cells.
Lee, Han-Teo; Lee, Il-Hwan; Kim, Jae-Hwan; Lee, Sangho; Kwak, Sojung; Suh, Min-Young; Hwang, In-Young; Kang, Bu-Gyeong; Cha, Sun-Shin; Lee, Byung-Il; Lee, Sang-Eun; Choi, Jinmi; Roe, Jae-Seok; Cho, Eun-Jung; Youn, Hong-Duk.
Afiliación
  • Lee HT; National Creative Research Center for Epigenome Reprogramming Network, Department of Biomedical Sciences, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Lee IH; Department of Molecular Medicine & Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 03080, Korea.
  • Kim JH; National Creative Research Center for Epigenome Reprogramming Network, Department of Biomedical Sciences, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Lee S; National Creative Research Center for Epigenome Reprogramming Network, Department of Biomedical Sciences, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Kwak S; National Creative Research Center for Epigenome Reprogramming Network, Department of Biomedical Sciences, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Suh MY; Department of Molecular Medicine & Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 03080, Korea.
  • Hwang IY; National Creative Research Center for Epigenome Reprogramming Network, Department of Biomedical Sciences, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Kang BG; National Creative Research Center for Epigenome Reprogramming Network, Department of Biomedical Sciences, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Cha SS; National Creative Research Center for Epigenome Reprogramming Network, Department of Biomedical Sciences, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Lee BI; Department of Chemistry & Nanoscience, Ewha Womans University, Seoul 03760, Korea.
  • Lee SE; Department of Chemistry & Nanoscience, Ewha Womans University, Seoul 03760, Korea.
  • Choi J; Research Institute, National Cancer Center, Goyang-si 10408, Korea.
  • Roe JS; Cardiology Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.
  • Cho EJ; National Creative Research Center for Epigenome Reprogramming Network, Department of Biomedical Sciences, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Youn HD; College of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea.
Cancers (Basel) ; 13(14)2021 Jul 08.
Article en En | MEDLINE | ID: mdl-34298635

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article